Budget impact analysis of including biosimilar adalimumab on formulary: A US payer perspective
J Manag Care Spec Pharm
.
2025 Jan;31(1):112-113.
doi: 10.18553/jmcp.2025.31.1.112.
Author
Sarah McGill
1
Affiliation
1
Monument Health, Home + Specialty Pharmacy, Rapid City, SD.
PMID:
39745846
PMCID:
PMC11695850
DOI:
10.18553/jmcp.2025.31.1.112
No abstract available
Publication types
Letter